• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经病理性疼痛4问卷阿拉伯语版本的开发与验证

Development and validation of Arabic version of the douleur neuropathique 4 questionnaire.

作者信息

Terkawi Abdullah Sulieman, Abolkhair Abdullah, Didier Bouhassira, Alzhahrani Tariq, Alsohaibani Mazen, Terkawi Yazzed Sulieman, Almoqbali Yousuf, Tolba Yasser Younis, Pangililan Evelyn, Foula Farida, Tsang Siny

机构信息

Department of Anesthesiology, University of Virginia, Charlottesville, VA, USA.

Department of Anesthesiology, King Fahd Medical City, Riyadh, Saudi Arabia.

出版信息

Saudi J Anaesth. 2017 May;11(Suppl 1):S31-S39. doi: 10.4103/sja.SJA_97_17.

DOI:10.4103/sja.SJA_97_17
PMID:28616002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5463565/
Abstract

INTRODUCTION

The douleur neuropathique 4 (DN4) questionnaire is a widely used tool for diagnosis of neuropathic pain (NP). The aim was to translate, culturally adapt, and validate the DN4 questionnaire in Arabic.

METHODS

A systematic translation process was used to translate the original English DN4 into Arabic. After the pilot study, the Arabic version was validated among patients with chronic pain in two tertiary care centers. The reliability of the translated version was examined using internal consistency, test-retest reliability, and intraclass correlation coefficients. We examined the validity of the Arabic DN4 via construct validity, concurrent validity (associations with the numeric rating scale, brief pain inventory, and Self-Completed Leeds Assessment of Neuropathic Symptoms and Signs [S-LANSS]), face validity, and diagnostic validity. To investigate the responsiveness, the translated DN4 was administered twice among the same group of patients.

RESULTS

A total of 142 subjects (68 men, 74 women) were included in the study. Cronbach's α was 0.67 (95% confidence interval [CI]: 0.59-0.75), and interclass correlation coefficients was 0.81 (95% CI: 0.76-0.87). The DN4 was moderately associated with the S-LANSS questionnaire. Results showed our Arabic DN4 to have good diagnostic accuracy, with area under the curve of 0.88 (95% CI: 0.82-0.94). As with the original version, a score of ≥4 was found to be the best cut-off for the diagnosis of NP, with a sensitivity of 88.31%, specificity of 74.47%, a positive predictive value of 85%, and a negative predictive value of 80%. Most patients found the DN4 questionnaire to be clear and easy to understand, and thought the questionnaire items covered all their problem areas regarding their pain.

CONCLUSION

Our Arabic version of the DN4 is a reliable and valid screening tool that can be easily administered among patients to differentiate between NP and non-NP.

摘要

引言

神经病理性疼痛4(DN4)问卷是一种广泛用于诊断神经病理性疼痛(NP)的工具。目的是将DN4问卷翻译成阿拉伯语,进行文化调适并验证其有效性。

方法

采用系统翻译流程将原始英文DN4问卷翻译成阿拉伯语。在预试验之后,在两个三级护理中心的慢性疼痛患者中对阿拉伯语版本进行验证。使用内部一致性、重测信度和组内相关系数来检验翻译版本的信度。我们通过结构效度、同时效度(与数字评定量表、简明疼痛问卷以及神经病理性症状和体征自我完成利兹评估[S-LANSS]的相关性)、表面效度和诊断效度来检验阿拉伯语DN4问卷的效度。为了研究反应度,在同一组患者中对翻译后的DN4问卷进行了两次发放。

结果

共有142名受试者(68名男性,74名女性)纳入研究。克朗巴哈α系数为0.67(95%置信区间[CI]:0.59 - 0.75),组内相关系数为0.81(95% CI:0.76 - 0.87)。DN4问卷与S-LANSS问卷呈中度相关。结果显示我们的阿拉伯语DN4问卷具有良好的诊断准确性,曲线下面积为0.88(95% CI:0.82 - 0.94)。与原始版本一样,发现≥4分是诊断NP的最佳截断值,灵敏度为88.31%,特异度为74.47%,阳性预测值为85%,阴性预测值为80%。大多数患者认为DN4问卷清晰易懂,并认为问卷项目涵盖了他们疼痛方面的所有问题领域。

结论

我们的阿拉伯语版DN4问卷是一种可靠且有效的筛查工具,可轻松应用于患者,以区分NP和非NP。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/5463565/fe27e3f08d7f/SJA-11-31-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/5463565/fe27e3f08d7f/SJA-11-31-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/5463565/fe27e3f08d7f/SJA-11-31-g005.jpg

相似文献

1
Development and validation of Arabic version of the douleur neuropathique 4 questionnaire.神经病理性疼痛4问卷阿拉伯语版本的开发与验证
Saudi J Anaesth. 2017 May;11(Suppl 1):S31-S39. doi: 10.4103/sja.SJA_97_17.
2
Development and validation of Arabic version of the Neuropathic Pain Questionnaire-Short Form.《神经病理性疼痛问卷简表》阿拉伯语版本的编制与验证
Saudi J Anaesth. 2017 May;11(Suppl 1):S53-S62. doi: 10.4103/sja.SJA_86_17.
3
Validation of Complete Hindi Version of Douleur Neuropathique 4 Questionnaire for Assessment of Neuropathic Pain.用于评估神经性疼痛的《神经病理性疼痛4问卷》印地语完整版的验证
Indian J Palliat Care. 2021 Apr-Jun;27(2):257-263. doi: 10.25259/IJPC_340_20. Epub 2021 Aug 12.
4
Development and validation of Arabic version of the Short-Form McGill Pain Questionnaire.《麦吉尔疼痛问卷简表阿拉伯语版的编制与验证》
Saudi J Anaesth. 2017 May;11(Suppl 1):S2-S10. doi: 10.4103/sja.SJA_42_17.
5
Validity and reliability of the Arabic adapted version of the DN4 questionnaire (Douleur Neuropathique 4 Questions) for differential diagnosis of pain syndromes with a neuropathic or somatic component.阿拉伯语适应版 DN4 问卷(DN4 问卷,即 4 个问题神经性疼痛问卷)用于鉴别诊断具有神经性或躯体性成分的疼痛综合征的有效性和可靠性。
Pain Pract. 2011 Mar-Apr;11(2):139-47. doi: 10.1111/j.1533-2500.2010.00399.x.
6
Development and validation of Arabic version of the pain catastrophizing scale.疼痛灾难化量表阿拉伯语版本的编制与验证
Saudi J Anaesth. 2017 May;11(Suppl 1):S63-S70. doi: 10.4103/sja.SJA_130_17.
7
Validation of a New Arabic Version of the Neuropathic Pain Diagnostic Questionnaire (DN4).新版阿拉伯语版神经性疼痛诊断问卷(DN4)的验证
Pain Pract. 2017 Jan;17(1):78-87. doi: 10.1111/papr.12419. Epub 2016 Feb 20.
8
Turkish version of the painDETECT questionnaire in the assessment of neuropathic pain: a validity and reliability study.疼痛 DETECT 问卷土耳其语版用于评估神经性疼痛的有效性和可靠性研究。
Pain Med. 2013 Dec;14(12):1933-43. doi: 10.1111/pme.12222. Epub 2013 Aug 7.
9
Nepalese version of Douleur Neuropathique 4 (DN4) questionnaire for detection of neuropathic pain signs and symptoms: Translation and psychometric properties.尼泊尔版的疼痛神经病理性问卷 4(DN4)用于检测神经病理性疼痛的体征和症状:翻译和心理测量特性。
PLoS One. 2023 Jul 17;18(7):e0287737. doi: 10.1371/journal.pone.0287737. eCollection 2023.
10
Hindi version of short form of douleur neuropathique 4 (S-DN4) questionnaire for assessment of neuropathic pain component: a cross-cultural validation study.用于评估神经性疼痛成分的神经病理性疼痛4型简短问卷(S-DN4)的印地语版本:一项跨文化验证研究。
Korean J Pain. 2017 Jul;30(3):197-206. doi: 10.3344/kjp.2017.30.3.197. Epub 2017 Jun 30.

引用本文的文献

1
Depression among outpatients with diabetic peripheral neuropathy: prevalence and associated factors.糖尿病周围神经病变门诊患者的抑郁:患病率及相关因素
Future Sci OA. 2025 Dec;11(1):2458989. doi: 10.1080/20565623.2025.2458989. Epub 2025 Jan 31.
2
Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination.新冠病毒感染的神经精神后遗留问题:流行率、严重程度和疫苗接种的影响。
Eur Arch Psychiatry Clin Neurosci. 2023 Sep;273(6):1349-1358. doi: 10.1007/s00406-023-01557-2. Epub 2023 Jan 27.
3
Possible Neuropathic Pain in Clinical Practice-Review on Selected Diagnostic Tools and Its Further Challenges.

本文引用的文献

1
Development and validation of Arabic version of the Neuropathic Pain Questionnaire-Short Form.《神经病理性疼痛问卷简表》阿拉伯语版本的编制与验证
Saudi J Anaesth. 2017 May;11(Suppl 1):S53-S62. doi: 10.4103/sja.SJA_86_17.
2
Development and validation of Arabic version of the Short-Form McGill Pain Questionnaire.《麦吉尔疼痛问卷简表阿拉伯语版的编制与验证》
Saudi J Anaesth. 2017 May;11(Suppl 1):S2-S10. doi: 10.4103/sja.SJA_42_17.
3
Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013.
临床实践中可能存在的神经性疼痛——关于选定诊断工具及其进一步挑战的综述
Diagnostics (Basel). 2022 Dec 29;13(1):108. doi: 10.3390/diagnostics13010108.
4
Factors associated with cognitive impairment at 3, 6, and 12 months after the first stroke among Lebanese survivors.黎巴嫩幸存者首次中风后 3、6 和 12 个月时认知障碍相关因素。
Brain Behav. 2023 Jan;13(1):e2837. doi: 10.1002/brb3.2837. Epub 2022 Dec 10.
5
Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case-control study.COVID-19 幸存者偏头痛患者的新冠后神经精神表现:病例对照研究。
J Headache Pain. 2022 Aug 12;23(1):101. doi: 10.1186/s10194-022-01468-y.
6
Progressive loss of corneal nerve fibers is associated with physical inactivity and glucose lowering medication associated with weight gain in type 2 diabetes.角膜神经纤维渐进性丧失与 2 型糖尿病患者的体力活动减少以及与体重增加相关的降血糖药物有关。
J Diabetes Investig. 2022 Oct;13(10):1703-1710. doi: 10.1111/jdi.13864. Epub 2022 Jun 20.
7
Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region.阿拉伯海湾地区糖尿病周围神经病变、神经病理性疼痛和足部溃疡的患病率及危险因素。
J Diabetes Investig. 2022 Sep;13(9):1551-1559. doi: 10.1111/jdi.13815. Epub 2022 May 5.
8
Psychometric and accuracy comparison of three commonly used questionnaires for the diagnosis of neuropathic pain.三种常用神经病理性疼痛诊断问卷的心理测量学及准确性比较
Saudi J Anaesth. 2021 Oct-Dec;15(4):409-418. doi: 10.4103/sja.sja_352_21. Epub 2021 Sep 2.
9
Psychological Complications at 3 Months Following Stroke: Prevalence and Correlates Among Stroke Survivors in Lebanon.中风后3个月的心理并发症:黎巴嫩中风幸存者中的患病率及相关因素
Front Psychol. 2021 Jun 10;12:663267. doi: 10.3389/fpsyg.2021.663267. eCollection 2021.
10
Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control.疼痛性糖尿病周围神经病变与 2 型糖尿病患者强化血糖控制后神经再生增加有关。
J Diabetes Investig. 2021 Sep;12(9):1642-1650. doi: 10.1111/jdi.13544. Epub 2021 May 3.
1990 - 2013年东地中海区域肌肉骨骼疾病负担:全球疾病负担研究2013的结果
Ann Rheum Dis. 2017 Aug;76(8):1365-1373. doi: 10.1136/annrheumdis-2016-210146. Epub 2017 Feb 16.
4
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家315种疾病和损伤的伤残调整生命年(DALYs)及健康预期寿命(HALE):全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1603-1658. doi: 10.1016/S0140-6736(16)31460-X.
5
Validation of the Greek Version of the DN4 Diagnostic Questionnaire for Neuropathic Pain.用于神经性疼痛的DN4诊断问卷希腊语版本的验证
Pain Pract. 2015 Sep;15(7):627-32. doi: 10.1111/papr.12221. Epub 2014 May 5.
6
Translation and linguistic validation of the self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) scale for use in a Libyan population.用于利比亚人群的自我完成的利兹评估神经性症状和体征(S-LANSS)量表的翻译和语言验证。
Pain Pract. 2013 Mar;13(3):198-205. doi: 10.1111/j.1533-2500.2012.00576.x. Epub 2012 Jun 22.
7
Validity and reliability of the Arabic adapted version of the DN4 questionnaire (Douleur Neuropathique 4 Questions) for differential diagnosis of pain syndromes with a neuropathic or somatic component.阿拉伯语适应版 DN4 问卷(DN4 问卷,即 4 个问题神经性疼痛问卷)用于鉴别诊断具有神经性或躯体性成分的疼痛综合征的有效性和可靠性。
Pain Pract. 2011 Mar-Apr;11(2):139-47. doi: 10.1111/j.1533-2500.2010.00399.x.
8
EFNS guidelines on neuropathic pain assessment: revised 2009.EFNS 指南:神经病病理性疼痛评估. 2009 修订版
Eur J Neurol. 2010 Aug;17(8):1010-8. doi: 10.1111/j.1468-1331.2010.02969.x. Epub 2010 Mar 8.
9
Translation to Portuguese and validation of the Douleur Neuropathique 4 questionnaire.翻译为葡萄牙语并验证《神经病理性疼痛 4 问卷》。
J Pain. 2010 May;11(5):484-90. doi: 10.1016/j.jpain.2009.09.014. Epub 2009 Dec 16.
10
Linguistic validation of the DN4 for use in international studies.用于国际研究的 DN4 语言验证。
Eur J Pain. 2010 Jan;14(1):58-63. doi: 10.1016/j.ejpain.2009.01.005. Epub 2009 Mar 17.